Cantor Fitzgerald Reiterates Overweight Rating on AbCellera Biologics (ABCL) Jul 17, 2026 09:55AM
AbCellera Biologics (ABCL) PT Raised to $11 at Cantor Fitzgerald Post Q1 Print, Trial Data May 12, 2026 09:27AM
Cantor Fitzgerald Starts AbCellera Biologics (ABCL) at Overweight May 5, 2026 06:08AM
Pre-Open Stock Movers 03/30: (MBRX) (ABCL) (SEEL) Higher; (WVE) (BFLY) (CLDX) Lower (more...) Mar 30, 2021 09:21AM